Agni Bio, Inc.
PrivateCompany Overview
Agni Bio, Inc. is a biotechnology company that develops bispecific antibody-based immunotherapies for the treatment of oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
bispecific antibodyimmunotherapydrug discoveryoncologyautoimmune diseasebiotechT-cell redirectionprotein engineeringbiologicstherapeutic pipelinesolid tumorspreclinical researchbiotech licensingdrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agni Bio, Inc. Comparables
Compare Agni Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomunex Pharmaceuticals | 78% | |
| Apeximmune Therapeutics | 77% | |
| Marengo Therapeutics | 76% | |
Agni Bio, Inc. Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Agni Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Agni Bio, Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersSouth San Francisco, California
Employee Range8
Year Founded2024
Last Funding—
See something wrong or outdated?